Canopy Growth (TSE:WEED – Get Free Report) had its price objective cut by investment analysts at ATB Capital from C$4.00 to C$3.20 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has an “underperform” rating on the stock. ATB Capital’s price target would indicate a potential upside of 13.48% from the stock’s current price.
Separately, Canaccord Genuity Group reduced their target price on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research report on Monday. Four analysts have rated the stock with a sell rating and one has issued a hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of C$5.40.
Check Out Our Latest Report on Canopy Growth
Canopy Growth Price Performance
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- Dividend Payout Ratio Calculator
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Capture the Benefits of Dividend Increases
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.